样式: 排序: IF: - GO 导出 标记为已读
-
Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases – Recommendations from the taskforce of the guideline workshop Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-12 James R. Gavin, Helena W. Rodbard, Tadej Battelino, Frank Brosius, Antonio Ceriello, Francesco Cosentino, Francesco Giorgino, Jennifer Green, Linong Ji, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Nebojsa Lalic, Nikolaus Marx, T. Prashant Nedungadi, Christopher G. Parkin, Pinar Topsever, Lars Rydén, Wayne Huey-Herng Sheu, Eberhard Standl, Per Olav Vandvik, Oliver Schnell
-
Tissue-specific inflammation and insulin sensitivity in subjects with obesity Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-12 S.M. Oussaada, M. Kilicarslan, B.A. de Weijer, P.W. Gilijamse, A. Şekercan, S. Virtue, I.M.C. Janssen, A. van de Laar, A. Demirkiran, B.A. van Wagensveld, A.P.J. Houdijk, A. Jongejan, P.D. Moerland, J. Verheij, T.B. Geijtenbeek, V.W. Bloks, M.C. de Goffau, J.A. Romijn, M. Nieuwdorp, A. Vidal-Puig, K.W. ter Horst, M.J. Serlie
Obesity is associated with low-grade inflammation and insulin resistance (IR). The contribution of adipose tissue (AT) and hepatic inflammation to IR remains unclear. We conducted a study across three cohorts to investigate this relationship.
-
Circulating immune cell phenotyping is potentially relevant for diabetic retinopathy risk assessment Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-10 Bo Li, Xu Zhao, Zhenzhen Hong, Yan Ding, Yi Zhang
Inflammation is believed to play a central role in the development of diabetes mellitus and is a common feature of type 2 diabetes mellitus (T2DM). However, the association with diabetic retinopathy (DR) remains a topic of debate. This study employed two-sample bidirectional Mendelian randomization (MR) analyses to establish causal associations between immune cell characteristics and DR. Using publicly
-
Verification of 2021 IDF-DAR risk assessment tool for fasting Ramadan in patients with diabetes attending primary health care in The Kingdom of Bahrain: The DAR-BAH study Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-10 Najla Shamsi, Jameel Naser, Hanan Humaidan, Abeer Al-Saweer, Masooma Jaafar, Fadheela Abbas, Sumaya Al-Doseri, Najat Shabeeb, Ebtihaj Al-Shaikh, AbdulRasool Al-Dairi, Khawla Mandoos
-
Associations between diabetes and cancer: A 10-year national population-based retrospective cohort study Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-09 Heléna Safadi, Ágnes Balogh, Judit Lám, Attila Nagy, Éva Belicza
To investigate the risk of cancer in people with diabetes compared to the population without diabetes and to gain insight into the timely association between diabetes and cancer at national level. A retrospective cohort study was conducted to analyse the role of diabetes in the development of cancer, based on service utilisation and antidiabetic dispensing data of the population between 2010 and 2021
-
Newly detected diabetes mellitus patients with acute coronary syndrome have an adverse cardiometabolic profile similar to patients with prior diabetes and a more extensive ischemic myocardial insult Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-09 Loukianos S Rallidis, Konstantinos A Papathanasiou, Donatos Tsamoulis, Vasileios Bouratzis, Ioannis Leventis, Charalampos Kalantzis, Belkis Malkots, Petros Kalogeras, Dimitrios Tasoulas, Iosif Delakis, Anastasios Lykoudis, Stylianos Daios, Victoria Potoupni, Stelios Zervakis, Athinagoras Theofilatos, Georgios Kotrotsios, Peggy M Kostakou, Konstantinos Kostopoulos, Pantelis Gounopoulos, Virginia Mplani
-
Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-09 Alhussain Yasin, Madison Nguyen, Angad Sidhu, Priyanka Majety, Jared Spitz, Amon Asgharpour, Mohammad S. Siddiqui, Laurence S. Sperling, Arshed A. Quyyumi, Anurag Mehta
The incidence and prevalence of metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are rising globally. MetS and T2DM are associated with significant morbidity and mortality, which is partly related to liver and cardiovascular disease. Insulin resistance is central to MetS and T2DM pathophysiology, and drives ectopic fat deposition in the liver, also known as metabolic dysfunction-associated
-
Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-09 Pann Ei Hnynn Si, S. Parker, D. Abdelhafiz, A. Summerbell, S. Muzulu, Ahmed H. Abdelhafiz
Metabolic targets are controversial in older people with type 2 diabetes due to functional heterogeneity and morbidity burden. Tight blood pressure and metabolic control appears beneficial in fit individuals who are newly diagnosed with type 2 diabetes and have fewer comorbidities. The benefits of low blood pressure and tight metabolic control is attenuated with the development of comorbidities, especially
-
Do WHO criteria for gestational diabetes fit a rural population in Tanzania? – A follow-up study assessing mother and child health six years after a pregnancy diagnosed with gestational diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-06 Camilla Byskou Eriksen, Daniel Thomas Minja, Dirk Lund Christensen, Ib Christian Bygbjerg, Peter Damm, Christentze Schmiegelow, Louise Groth Grunnet, Line Hjort
-
The use of potentially interacting supplement–drug pairs in adults with type 2 diabetes: A large population-based cohort study in the UK Biobank Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-05 Rong Hua, Chun Sing Lam, Yu Kang Wu, Weishang Deng, Natural Chu, Aimin Yang, Elaine Chow, Yin Ting Cheung
To examine the patterns of use of potentially interacting supplement–drug pairs in adults with type 2 diabetes (T2D) in real-world settings, and to explore the impact of potentially interacting supplement–drug pairs on downstream outcomes. Potentially interacting supplement–drug pairs were identified from four tertiary databases. We categorized the potential pharmacodynamic interactions into different
-
Insulin icodec use in hospital settings: Considerations for once-weekly basal insulin therapy in hospital glycaemic management practice Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-05 Rahul D. Barmanray, Mervyn Kyi, Gerry Rayman, Robert Rushakoff, Philip Newland-Jones, Spiros Fourlanos
-
Corrigendum to “The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care” [Diabetes Res. and Clin. Pract. 199 (2023) 110672] Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-04 G. Russo, P. Di Bartolo, R. Candido, G. Lucisano, V. Manicardi, A. Giandalia, A. Nicolucci, A. Rocca, M.C. Rossi, G. Di Cianni, on behalf of the AMD Annals Study Group
-
Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-03 Geltrude Mingrone, Harith Rajagopalan
The burden of chronic metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and metabolic dysfunction-associated steatotic liver disease (MASLD) and the urgency of the epidemiological situation necessitate the development of therapies that enhance metabolic health and alter the trajectory of metabolic disease in society. Certain bariatric-metabolic surgeries have proven to be effective
-
Diagnostic performance of the GGT/HDL-C ratio for NAFLD in adults with obesity undergoing bariatric surgery Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-03 Renzo Pajuelo-Vasquez, Jerry K. Benites-Meza, Hilda V. Durango-Chavez, Gustavo Salinas-Sedo, Carlos J. Toro-Huamanchumo
Non-alcoholic fatty liver disease (NAFLD) has become the most frequent liver disease, closely related with metabolic risk factors such as obesity, insulin resistance, dyslipidemia, diabetes mellitus, and metabolic syndrome. In this context, γ-Glutamyl transpeptidase (GGT) and high-density lipoprotein cholesterol (HDL-C) have shown correlations with steatosis severity and metabolic syndrome, respectively
-
Prevalence of gestational diabetes mellitus risk factors in singleton pregnancies obtained by assisted reproductive technology: An observational, retrospective, real-world study from a pregnancy registry Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-02 Michela Vergani, Matteo Conti, Alessia Lari, Elena Mion, Federico Bertuzzi, Basilio Pintaudi
Several studies showed that Assisted Reproductive Technology (ART) could affect gestational diabetes mellitus (GDM) onset. The aim of this study was to estimate the prevalence of GDM risk factors in a cohort of women with singleton pregnancy obtained by ART and complicated by GDM. Maternal and neonatal outcomes were explored. We retrospectively collected data of pregnancies of women with singleton
-
Efficacy of a phone reminder to improve adherence to post-partum glucose tolerance testing after gestational diabetes and clinical predictors of post-partum follow-up compliance Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-02 Agostino Milluzzo, Lucia Manuella, Lucia Frittitta, Laura Sciacca
To assess the effectiveness of a phone reminder to improve adherence to post-partum glucose tolerance testing in women with gestational diabetes mellitus (GDM) and to identify clinical predictors of adherence to post-partum follow-up. Retrospective study including 543 women with GDM. We assessed the adherence rate to post-partum glucose tolerance testing in women who received a phone reminder (n = 297)
-
Epidemiology of NAFLD – Focus on diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-04-02 Zobair M. Younossi, Linda Henry
There is increasing appreciation of the complex interaction between nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D) and insulin resistance. Not only is the prevalence of NAFLD disease high among patients with T2D, the liver disease is also more progressive. Currently, the global prevalence of NAFLD in the general population (2016–2019) is 38 %. The prevalence of T2D among those
-
Cardiovascular risk and access to primary care: Comparisons among Chinese documented and undocumented immigrants Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-29 Alessio Pellegrino, Maria Calabrese, Maria Boddi, Irene Vacirca, Cecilia Baccari, Laura Bonvicini, Francesco Venturelli, Alessio Petrelli, Anteo Di Napoli, Maria Perticone, Paolo Giorgi Rossi, Pietro Amedeo Modesti
-
IDF23-0572 A Phase IV study to assess safety and efficacy of FDC of Remogliflozin, Metformin and Vildagliptin in management of T2DM Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Mane, S. Bhushan, S. Creado, G. Singh, R. Gadkari, S. Suryawanshi, H. Barkate
-
IDF23-0567 Impacts of leisure time physical activity for type-2 diabetic patients: A systematic review Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M.M. Rahman
-
IDF23-0563 Medial Arterial Calcification of the Internal Carotid Artery: A Sensitive Radiographic Marker for Diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Dayo, D. Miles, P. Corby
-
IDF23-0562 Comparison of Insulin GlargineU300 and Insulin Degludec100 on CGM and conventional metrics in Indian Type 2 Diabetics Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M. Sabharwal
-
IDF23-0561 The spectrum of thyroid dysfunction and thyroid autoimmunity in Type 1 diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Gupta
-
IDF23-0560 The prevalence of Endogenous Cushing syndrome (CS) in adults with diabetes mellitus in Eastern India Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Gupta, M. Bera, A. Baidya, R. Ahmed
-
IDF23-0559 Metabolic comorbidities in relatives of patients with T2DM: Implications for Prevention and Care Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A.C. García Ulloa, K.S. Lugo-Bautista, V. Martínez-Sánchez, L. Pérez-Peralta, S.C. Hernandez-Jimenez
-
IDF23-0558 A Federated Learning Approach for Type-2 Diabetes Detection Using a Naive Bayes Classifier Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M.M. Rahman, A. Islam, S.T. Pasha, M.U. Islam, M.Z. Alam
-
IDF23-0556 Comparative Evaluation of Cleansing Agent Super-Oxidized Solution and Polyhexamethylene Biguanide 0,25% on Chronic Wound Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 K. Bahri
-
IDF23-0555 Decrease of glycemia with extracts of Plathymenia reticulate Benth and Azadirachta indica (Neem) in obese rats Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 L.V. Oliveira Silva, F. Oliveira Magalhães, P. Ibler Bernardo Ceron, G. Braga de Paula Cançado, B. Rabelo Tavares, I. Faria de Mello, M.E. Franco, S. Ferreira, M. Silva Paiva, C. Schlischka, R. Pacheco Policarpo, L. Augusto Alves Silva
-
IDF23-0553 Lipocalin-2 as a therapeutic target for bone fragility as a type 2 diabetes complication Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 D.L. Solis-Suarz
-
IDF23-0546 Weight gain reduction with extracts of Plathymenia reticulate Benth and Neem in type 2 diabetic rats Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 C. Schlischka Sivieri, G. Braga de Paula Cançado, F. Oliveira Magalhães, L. Augusto Alves Silva, I. Faria de Mello, M.E. Franco, S. Ferreira, M. Silva Paiva, L.V. Oliveira Silva, M.E. Santos Resende, R. Pacheco Policarpo, B. Rabelo Tavares
-
IDF23-0543 Canagliflozin improves renal phenotype and restores beta-cell identity in an early-onset T2D model Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A.I. Popescu, P. Ray, R.C. Bunn, J.L. Fowlkes, K.M. Thrailkill
-
IDF23-0541 Decrease of lipids with extracts of Plathymenia reticulata Benth and Azadirachta indica (Neem) in obese rats Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 S. Ferreira, F. Oliveira Magalhães, G. Braga de Paula Cançado, L. Augusto Alves Silva, C. Sivieri Schlischka, L. Vitória Oliveira Silva, M.E. Franco, M.E. Santos Resende, P. Ibler Bernardo Ceron, B. Rabelo Tavares, R. Pacheco Policarpo, I. Faria de Mello
-
IDF23-0538 Bulgarian community pharmacists' knowledge towards diabetes mellitus management: results of a pilot survey Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 R. Staynova, E. Gavazova, V. Yanachkova, D. Kafalova
-
IDF23-0530 Safety of Guardian Connect CGM system in early postoperative period after total duodenopancreatectomy Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Farmanov, E. Bublik, A. Zilov, O. Vinogradskaya, E. Ryzhkova, V. Egorov, V. Fadeyev, O. Udovichenko, S. Deunezheva
-
IDF23-0526 Obesity in Children Diagnosed with type 1 Diabetes: Prevalence and Impact on Glycemic Control and Renal Function Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 B. Alnajjar, J. Lakshmi, I. Ferreira, A. Akil
-
IDF23-0514 Overview of DM Complications in Beneficiaries of a Self-Managed Healthcare Provider in Brazil Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 D. Monteiro Cavalcante, D.F. Oliveira, F.A. Freitas, F.N.S. Lima, R.F.B. Bernardo, W.V.D.S. Rosa
-
IDF23-0512 Poor glycemic control and complications prevalence in elderly from Health, Well-being and Aging Study, Brazil, 2010–2015 Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 P. Santucci, R. Koga, Y. Duarte
-
IDF23-0508 Abnormal peri-spinal neurovascular responses in nonneuropathic type II diabetes patients: a novel diagnostic method Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 J.E. Oyarzun, R. Caulier-Cisterna, J.P. González-Appelgren, A. Eblen-Zajjur, S. Uribe
-
IDF23-0506 Insulin level and HOMA-IR are negatively associated with telomere length in Mexican children Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 B. Murillo-Ortiz, A. Perales-Herrera, J.C. Paredes-Barrientos, M. Cruz, M. Vazquez-Moreno
-
IDF23-0504 Low Diabetes Risk Perception in University Students-A Barrier in the Prevention of Diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 S. Venugopal, K. Shah, U. Iyer
-
IDF23-0503 Exploring factors influencing diabetes-related complications in a Northwestern Community, Ontario, Canada Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 I.G. Costa, K. Adduono, K. McConnell, P. Camargo-Plazas, A. Kone
-
IDF23-0500 Children with diabetes compared to peers: depressed? Distressed? Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 B. Saboo, S. Saboo, A. Inamdar
-
IDF23-0499 Associated Factors of Anxiety Among Patients with Type 2 Diabetes in an Endocrinology Center, Kairouan Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 W. Debbabi, H. Sakly, I. Kharrat, K. Hachani, W. Saidi, S. Samet
-
IDF23-0497 Results from Phase 1 Landscaping of the Diabetes CarePak project to improve self-management of diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M. Hodges, S. Wood, G. Robi, J. Samoei
-
IDF23-0495 Association between Glycemic parameters & Hemoglobin in Diabetic patients - A multicentre cross-sectional study in India Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Maheshwari, J. Fatima, D. Saxena, K.P. Chandra, A. Dinkar, B.K. Gupta, N. Verma, N. Kanodia, P. Chawla, B. Patni, A. Srivastava, A. Tewari
-
IDF23-0491 Anemia Among Type 2 Diabetes Mellitus Patients - AClinic Based Cross-sectional Study in India Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Maheshwari, D. Saxena, J. Fatima, M. Aslam, J. Singh, N. Lodha, U. Rathod, D. Hasnani, C.L. Nawal, G. Chhaya, S. Singla, S.J. Jha
-
IDF23-0487 Baseline Assessment on integration of insulin into vaccine cold chain systems in the Ga West Municipality, Ghana Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M. Hodges, G. Amofah, P. Cofie, H. McGuire
-
IDF23-0486 Influence of body composition on bone mineral content among adult ambulatory T2D patients Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M. Bera, M.K. Guha, R. Ahmed, A. Gupta
-
IDF23-0479 Community clinics increase access to paediatric type 1 diabetes screening research for minority ethnic groups in the UK Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 L. Quinn, V. Sheth, F. Zakia, C. Burt, R. Dias, A. Richter, P. Narendran
-
IDF23-0476 Comparative Study on Diabetes Complications and CAM Utilization: A Control Group Analysis Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 J. Kesavadev, A. Shankar, S.R. Joshi, G. Krishnan, A. Basanth, S. Jothydev
-
IDF23-0474 A Community-Based Survey on Treatment Challenges and Management Gaps in Type 1 Diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 J. Kesavadev, A. Shankar, B. Saboo, G. Krishnan, A. Ashik, A. Basanth, G. Beena Chandran, G. Sanal, S. Jothydev
-
IDF23-0471 Impact of onion-based interventions on biomarkers of diabetes and its complications in diabetic rats-A systematic review Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M. Pandey, M. Pathri, S. Labani, S. Nagarajan
-
IDF23-0464 Glycemic Control, Insulin Requirements and Pregnancy Outcomes In Women With Type 1 Diabetes In Pregnancy. Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 A. Jamali, A. Sheikh, M. Kazi, S. Awan, L. Sheikh, N. Islam
-
IDF23-0462 Model of Care for Type 1 Diabetes in West Bengal, India: Baseline Data Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 M. Yasmin, P. Mukhopadhyay, D.K. Mukhopadhyay, B. Paul, S. Ghosh
-
IDF23-0458 Management of Steroid-Induced Hyperglycemia: A Case Report of Diabetes Mellitus Patient during COPD Acute Exacerbation Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 S. Firdausa, S. Suryawati, F. Noor Liani, B. Yanti, T. Mamfaluti, M. Hasan, M.L. Siregar
-
IDF23-0456 Awareness of EDKA associated with usage of SGLT2i – an emerging life-threatening complication in management of diabetes Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 C. Yip, H.T. Chau, L.Y. Chau, T.F.V. Yeung
-
IDF23-0455 Effects of Alternate Insulin Pump Settings in PatientsWith Type 1 Diabetes During Ramadan: A Randomized Pilot Study Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 G. Alghatam, D. O'Keeffe, H. Taha
-
IDF23-0454 Prevalence of Hemoglobin variants in T2DM through HbA1c assessment Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 S. Gupta, A. Baig, S. Gupta, S. Gupta
-
IDF23-0447 Risk of type 2 diabetes mellitus in adult emergency nursing personnel, Third Level Hospital, Honduras, July 2023 Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 R.Y. Maradiaga
-
IDF23-0446 Using an Ensemble Machine Learning Model with Explainable AI (XAI) to Diagnose Gestational Diabetes Mellitus Diabetes Res. Clin. Pract. (IF 5.1) Pub Date : 2024-03-28 S.T. Pasha, S. Sikder, M.M. Rahman, A. Islam, M.Z. Alam, M.T. Habib, M.A. Amin